Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Prescribed Opioids Raise Pneumonia Risk
Opioid-related research developments of interest to pharmacists.
An Overview of Naloxone for Pharmacists
The most common medications involved in prescription-opioid overdose deaths include methadone, oxycodone, and hydrocodone.
Management of Acute Ischemic Stroke: a Review of Pertinent Guideline Updates
There have been significant evidence-based literature updates regarding the management of acute ischemic stroke (AIS) in adult patients; these are discussed in a 2018 guideline update.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.